{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T16:23:38Z","timestamp":1781108618884,"version":"3.54.1"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1007467","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:00:00Z","timestamp":1573084800000}}],"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T00:00:00Z","timestamp":1572220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011568","name":"Huck Institutes of the Life Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011568","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1007467","type":"journal-article","created":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T13:35:55Z","timestamp":1572269755000},"page":"e1007467","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Evolution of the nonsense-mediated decay pathway is associated with decreased cytolytic immune infiltration"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4610-1707","authenticated-orcid":true,"given":"Boyang","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7749-4473","authenticated-orcid":true,"given":"Justin R.","family":"Pritchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,10,28]]},"reference":[{"key":"pcbi.1007467.ref001","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1126\/science.aaf1490","article-title":"Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade","volume":"351","author":"N McGranahan","year":"2016","journal-title":"Science"},{"key":"pcbi.1007467.ref002","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer","volume":"348","author":"NA Rizvi","year":"2015","journal-title":"Science"},{"key":"pcbi.1007467.ref003","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.ccell.2018.04.001","article-title":"Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer","volume":"33","author":"MD Hellmann","year":"2018","journal-title":"Cancer Cell"},{"key":"pcbi.1007467.ref004","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","article-title":"Molecular and genetic properties of tumors associated with local immune cytolytic activity","volume":"160","author":"MS Rooney","year":"2015","journal-title":"Cell"},{"key":"pcbi.1007467.ref005","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nature13954","article-title":"PD-1 blockade induces responses by inhibiting adaptive immune resistance","volume":"515","author":"PC Tumeh","year":"2014","journal-title":"Nature"},{"key":"pcbi.1007467.ref006","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.celrep.2018.03.086","article-title":"Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images","volume":"23","author":"J Saltz","year":"2018","journal-title":"Cell Rep"},{"key":"pcbi.1007467.ref007","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1158\/2159-8290.CD-16-1223","article-title":"Primary Resistance to PD-1 Blockade Mediated by JAK1\/2 Mutations","volume":"7","author":"DS Shin","year":"2017","journal-title":"Cancer Discov"},{"key":"pcbi.1007467.ref008","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1604958","article-title":"Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma","volume":"375","author":"JM Zaretsky","year":"2016","journal-title":"N Engl J Med"},{"key":"pcbi.1007467.ref009","first-page":"397","article-title":"Loss of IFN-\u03b3 Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4","volume":"167","author":"J Gao","year":"2016","journal-title":"Therapy. Cell"},{"key":"pcbi.1007467.ref010","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","article-title":"Nivolumab versus Docetaxel in Advanced Nonsquamous Non\u2013Small-Cell Lung Cancer","volume":"373","author":"H Borghaei","year":"2015","journal-title":"N Engl J Med"},{"key":"pcbi.1007467.ref011","doi-asserted-by":"crossref","first-page":"254ra128","DOI":"10.1126\/scitranslmed.3008918","article-title":"Anti-CTLA-4 therapy broadens the melanoma-reactive CD8+ T cell response","volume":"6","author":"P Kvistborg","year":"2014","journal-title":"Sci Transl Med"},{"key":"pcbi.1007467.ref012","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma","volume":"373","author":"J Larkin","year":"2015","journal-title":"N Engl J Med"},{"key":"pcbi.1007467.ref013","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1056\/NEJMoa1712126","article-title":"Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma","volume":"378","author":"RJ Motzer","year":"2018","journal-title":"N Engl J Med"},{"key":"pcbi.1007467.ref014","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","article-title":"Pembrolizumab versus Chemotherapy for PD-L1\u2013Positive Non\u2013Small-Cell Lung Cancer","volume":"375","author":"M Reck","year":"2016","journal-title":"N Engl J Med"},{"key":"pcbi.1007467.ref015","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1158\/1078-0432.CCR-15-2834","article-title":"Pan-Cancer Immunogenomic Perspective on the Tumor Microenvironment Based on PD-L1 and CD8 T-Cell Infiltration","volume":"22","author":"CY Ock","year":"2016","journal-title":"Clin Cancer Res"},{"key":"pcbi.1007467.ref016","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1158\/2159-8290.CD-16-0828","article-title":"Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non\u2013Small Cell Lung Cancer","volume":"7","author":"V Anagnostou","year":"2017","journal-title":"Cancer Discov"},{"key":"pcbi.1007467.ref017","first-page":"NEJMoa1801946","article-title":"Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden","author":"MD Hellmann","year":"2018","journal-title":"N Engl J Med"},{"key":"pcbi.1007467.ref018","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.celrep.2016.03.075","article-title":"Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma","volume":"15","author":"M Giannakis","year":"2016","journal-title":"Cell Rep"},{"key":"pcbi.1007467.ref019","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1126\/science.aad0095","article-title":"Genomic correlates of response to CTLA-4 blockade in metastatic melanoma","volume":"350","author":"EM Van Allen","year":"2015","journal-title":"Science"},{"key":"pcbi.1007467.ref020","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood-2014-04-567933","article-title":"Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia","volume":"124","author":"M Rajasagi","year":"2014","journal-title":"Blood"},{"key":"pcbi.1007467.ref021","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1126\/science.aad0095","article-title":"Genomic correlates of response to CTLA-4 blockade in metastatic melanoma","volume":"350","author":"EM Van Allen","year":"2015","journal-title":"Science"},{"key":"pcbi.1007467.ref022","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The Immune Landscape of Cancer","volume":"48","author":"V Thorsson","year":"2018","journal-title":"Immunity"},{"key":"pcbi.1007467.ref023","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/nbt.4239","article-title":"Intron retention is a source of neoepitopes in cancer","volume":"36","author":"AC Smart","year":"2018","journal-title":"Nat Biotechnol"},{"key":"pcbi.1007467.ref024","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S1470-2045(17)30516-8","article-title":"Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis","volume":"18","author":"S Turajlic","year":"2017","journal-title":"Lancet Oncol"},{"key":"pcbi.1007467.ref025","first-page":"4213","article-title":"Frequent frameshift mutations of the TCF-4 gene in colorectal cancers with microsatellite instability","volume":"59","author":"A Duval","year":"1999","journal-title":"Cancer Res"},{"key":"pcbi.1007467.ref026","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/ng.3664","article-title":"The rules and impact of nonsense-mediated mRNA decay in human cancers","volume":"48","author":"RGH Lindeboom","year":"2016","journal-title":"Nat Genet"},{"key":"pcbi.1007467.ref027","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nature08999","article-title":"Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay","volume":"465","author":"F Pastor","year":"2010","journal-title":"Nature"},{"key":"pcbi.1007467.ref028","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1056\/NEJMoa1501824","article-title":"Pembrolizumab for the Treatment of Non\u2013Small-Cell Lung Cancer","volume":"372","author":"EB Garon","year":"2015","journal-title":"N Engl J Med"},{"key":"pcbi.1007467.ref029","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nrg2402","article-title":"The multiple lives of NMD factors: Balancing roles in gene and genome regulation","volume":"9","author":"O Isken","year":"2008","journal-title":"Nat Rev Genet"},{"key":"pcbi.1007467.ref030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2018.00270","article-title":"Biomarkers for immune checkpoint inhibitors in melanoma","volume":"8","author":"S Kitano","year":"2018","journal-title":"Front Oncol"},{"key":"pcbi.1007467.ref031","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1158\/1535-7163.MCT-17-0386","article-title":"Tumor mutational burden as an independent predictor of response to immunotherapy in diverse cancers","volume":"16","author":"AM Goodman","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"pcbi.1007467.ref032","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.cell.2017.10.001","article-title":"Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution","volume":"0","author":"N McGranahan","year":"2017","journal-title":"Cell"},{"key":"pcbi.1007467.ref033","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1101\/gr.165985.113","article-title":"Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival","volume":"24","author":"SD Brown","year":"2014","journal-title":"Genome Res"},{"key":"pcbi.1007467.ref034","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/nbt.3344","article-title":"Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes","volume":"33","author":"SA Shukla","year":"2015","journal-title":"Nat Biotechnol"},{"key":"pcbi.1007467.ref035","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nbt.3800","article-title":"The problem with neoantigen prediction","volume":"35","year":"2017","journal-title":"Nat Biotechnol"},{"key":"pcbi.1007467.ref036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13073-017-0424-2","article-title":"Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden","volume":"9","author":"ZR Chalmers","year":"2017","journal-title":"Genome Med"},{"key":"pcbi.1007467.ref037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13578-017-0153-7","article-title":"Control of gene expression through the nonsense-mediated RNA decay pathway","volume":"7","author":"A Nickless","year":"2017","journal-title":"Cell Biosci"},{"key":"pcbi.1007467.ref038","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/nm.4191","article-title":"Classification and characterization of microsatellite instability across 18 cancer types","volume":"22","author":"RJ Hause","year":"2016","journal-title":"Nat Med"},{"key":"pcbi.1007467.ref039","first-page":"1","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"J Gao","year":"2013","journal-title":"Sci Signal"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1007467","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:00:00Z","timestamp":1573084800000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1007467","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T13:58:17Z","timestamp":1573135097000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1007467"}},"subtitle":[],"editor":[{"given":"Vassily","family":"Hatzimanikatis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,10,28]]},"references-count":39,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1007467","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pcbi.1007467","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,28]]}}}